Novozymes A/S (CPH:NSIS.B)
424.60
+7.20 (1.72%)
Aug 14, 2026, 4:59 PM CET
Novozymes Market Cap
Novozymes has a market cap or net worth of 197.83 billion as of August 14, 2026. Its market cap has increased by 1.35% in one year.
Market Cap
197.83B
Enterprise Value
219.39B
Revenue
31.39B
Ranking
n/a
PE Ratio
44.43
Stock Price
424.60
ChartMarket Cap Chart
Since February 26, 2001, Novozymes's market cap has increased from 14.15B to 197.83B, an increase of 1,298.25%. That is a compound annual growth rate of 10.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 197.83B | 4.18% |
| Dec 30, 2025 | 189.89B | 0.24% |
| Dec 30, 2024 | 189.43B | 84.24% |
| Dec 29, 2023 | 102.82B | 5.66% |
| Dec 30, 2022 | 97.30B | -34.61% |
| Dec 30, 2021 | 148.80B | 51.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DSV A/S | 343.12B |
| Danske Bank | 301.89B |
| A.P. Møller - Mærsk | 290.62B |
| Vestas Wind Systems | 200.94B |
| Ørsted | 183.89B |
| Carlsberg | 127.92B |
| Genmab | 121.01B |
| Coloplast | 96.44B |